Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 7/20 | 0.74 |
| ▸ | NPY4R | P50391 | 7/20 | 0.74 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.74 |
| ▸ | NPY1R | P25929 | 5/20 | 0.74 |
| ▸ | GLP1R | P43220 | 6/20 | 0.71 |
| ▸ | CXCR4 | P61073 | 5/20 | 0.67 |
| ▸ | ECE1 | P42892 | 1/20 | 0.67 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30721554 | 0.96 | NPY2R (0.76) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30658244 | 0.95 | NPY2R (0.76) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30658277 | 0.94 | NPY2R (0.75) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL31182921 | 0.94 | NPY2R (0.76) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30658289 | 0.94 | NPY2R (0.73) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL31182522 | 0.94 | NPY2R (0.71) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30658333 | 0.94 | NPY2R (0.73) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30494418 | 0.94 | NPY2R (0.67) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL30607478 | 0.93 | NPY2R (0.72) | NPY2RNPY4RNPY5RNPY1RGLP1R | |
| SCHEMBL29679866 | 0.93 | NPY1R (0.72) | NPY2RNPY4RNPY5RNPY1RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11925667-B2 | Engineered therapeutic probiotic system and method | CHANG MATTHEW WOOK (SG) | 2024-03-12 | — | — | US | disclosed |